On 1st of June, 2004, the president of SK Bio-pharmaceutical Enterprise, Mr Cui Rongwen made a visit to Tasly Modern TCM city. The general manager of Tasly Importing and Exporting trade company , Mr. Zhu Yonghong, warmly welcomed the visitors from Korea.
SKBP is mainly investing on the R&D of the bio-pharmaceutical products. Their two category products, one is for anti-depression and another is for anti-epilepsy, which have already obtained FDA s IND authorization certificate issued by USA. SKBP has cooperated with American Johnson &Johnson Company. Johnson &Johnson is commercializing SKBP products.
All the visitors from Korea accompanied by general manager Zhu Ronghong, took a visit to Tasly Chinese Medicine engraving, Chinese herbal planting garden, preparation workshop of Tasly pharmaceutical Co., Ltd. The visitors showed their surprise and plastered their high praise to Tasly production scale, annual production capacity, and standardized management
Tasly TCM City left a strong impression to the visitors from South Korea, thus held their great interest in investing on Chinese herbal medicine.
